SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 40 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $800 | -100.0% | 428,000 | -84.5% | 0.00% | -100.0% |
| Q3 2022 | $4,638,000 | +15.1% | 2,761,000 | -13.4% | 0.01% | +150.0% |
| Q2 2022 | $4,028,000 | -9.2% | 3,187,000 | -5.6% | 0.00% | -33.3% |
| Q1 2022 | $4,434,000 | -59.1% | 3,376,000 | -54.9% | 0.00% | +50.0% |
| Q4 2021 | $10,838,000 | +173.7% | 7,480,000 | +181.3% | 0.00% | 0.0% |
| Q3 2021 | $3,960,000 | +10.6% | 2,659,000 | -1.2% | 0.00% | 0.0% |
| Q2 2021 | $3,579,000 | -23.5% | 2,691,000 | -24.8% | 0.00% | -33.3% |
| Q1 2021 | $4,677,000 | +426.1% | 3,580,000 | +517.2% | 0.00% | +200.0% |
| Q1 2020 | $889,000 | -17.0% | 580,000 | +5.3% | 0.00% | 0.0% |
| Q4 2019 | $1,071,000 | +157.5% | 551,000 | +74.9% | 0.00% | – |
| Q3 2019 | $416,000 | +462.2% | 315,000 | +826.5% | 0.00% | – |
| Q2 2019 | $74,000 | -79.8% | 34,000 | -83.3% | 0.00% | – |
| Q1 2019 | $366,000 | – | 203,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 92,999,000 | $138,298,000 | 4.13% |
| WOLVERINE ASSET MANAGEMENT LLC | 84,505,000 | $125,210,000 | 1.08% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 20,000,000 | $29,789,000 | 0.79% |
| Verition Fund Management LLC | 27,047,000 | $40,063,000 | 0.35% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 7,970,000 | $11,789,000 | 0.22% |
| Baker Brothers Advisors | 29,174,000 | $43,167,000 | 0.19% |
| Calamos Advisors LLC | 23,631,000 | $35,035,000 | 0.15% |
| RWC Asset Management LLP | 2,900,000 | $4,300,000 | 0.13% |
| Aequim Alternative Investments LP | 1,957,000 | $2,899,000 | 0.11% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,148,000 | $4,666,000 | 0.10% |